中华医学杂志
中華醫學雜誌
중화의학잡지
National Medical Journal of China
2012年
37期
2624-2627
,共4页
李少雷%郑庆锋%陈晋峰%吴楠%阎石%王宇昭%吕超%张力建%杨跃
李少雷%鄭慶鋒%陳晉峰%吳楠%閻石%王宇昭%呂超%張力建%楊躍
리소뢰%정경봉%진진봉%오남%염석%왕우소%려초%장력건%양약
体层摄影术,X线计算机%血管内皮生长因子C%癌,非小细胞肺
體層攝影術,X線計算機%血管內皮生長因子C%癌,非小細胞肺
체층섭영술,X선계산궤%혈관내피생장인자C%암,비소세포폐
Tomography,X-ray computed%Vascular endothelial growth factor C%Carcinoma,non-small-cell lung
目的 观察胸部增强计算机断层显像(CT)联合血管内皮生长因子C(VEGF-C)的表达检测对肺门和(或)纵隔淋巴结转移的诊断价值.方法 2008年3月至2010年3月北京大学肿瘤医院胸外二科87例非小细胞肺癌(NSCLC)患者,术前行胸部增强CT扫描,并接受标准肺癌根治手术及系统性淋巴结清扫,术后病理检查为判断淋巴结是否转移金标准.术后采用免疫组化方法检测VEGF-C在癌组织中的表达.回顾性分析CT和VEGF-C对淋巴结转移的预测作用,并比较其灵敏度、特异度和准确性等.结果 对淋巴结转移的诊断,CT的灵敏度为75.0%,特异度为59.6%,准确性66.7%.肺癌组织中VEGF-C的表达阳性率为78.2% (68/87),其中强阳性占13.8%(12/87),其对淋巴结转移的诊断灵敏度为97.5%,特异度为38.3%,准确性为65.5%.当CT联合VEGF-C诊断时,其灵敏度为80.0%,特异度为70.2%,准确性为74.7%.结论 CT检查联合VEGF-C表达检测能提高NSCLC肺门及纵隔淋巴结转移诊断的特异性和准确性,优于CT或VEGF-C单独应用,提示应用CT扫描进行临床N分期时,如能同时对癌组织进行VEGF-C检测,可能会提高分期的准确性.
目的 觀察胸部增彊計算機斷層顯像(CT)聯閤血管內皮生長因子C(VEGF-C)的錶達檢測對肺門和(或)縱隔淋巴結轉移的診斷價值.方法 2008年3月至2010年3月北京大學腫瘤醫院胸外二科87例非小細胞肺癌(NSCLC)患者,術前行胸部增彊CT掃描,併接受標準肺癌根治手術及繫統性淋巴結清掃,術後病理檢查為判斷淋巴結是否轉移金標準.術後採用免疫組化方法檢測VEGF-C在癌組織中的錶達.迴顧性分析CT和VEGF-C對淋巴結轉移的預測作用,併比較其靈敏度、特異度和準確性等.結果 對淋巴結轉移的診斷,CT的靈敏度為75.0%,特異度為59.6%,準確性66.7%.肺癌組織中VEGF-C的錶達暘性率為78.2% (68/87),其中彊暘性佔13.8%(12/87),其對淋巴結轉移的診斷靈敏度為97.5%,特異度為38.3%,準確性為65.5%.噹CT聯閤VEGF-C診斷時,其靈敏度為80.0%,特異度為70.2%,準確性為74.7%.結論 CT檢查聯閤VEGF-C錶達檢測能提高NSCLC肺門及縱隔淋巴結轉移診斷的特異性和準確性,優于CT或VEGF-C單獨應用,提示應用CT掃描進行臨床N分期時,如能同時對癌組織進行VEGF-C檢測,可能會提高分期的準確性.
목적 관찰흉부증강계산궤단층현상(CT)연합혈관내피생장인자C(VEGF-C)적표체검측대폐문화(혹)종격림파결전이적진단개치.방법 2008년3월지2010년3월북경대학종류의원흉외이과87례비소세포폐암(NSCLC)환자,술전행흉부증강CT소묘,병접수표준폐암근치수술급계통성림파결청소,술후병리검사위판단림파결시부전이금표준.술후채용면역조화방법검측VEGF-C재암조직중적표체.회고성분석CT화VEGF-C대림파결전이적예측작용,병비교기령민도、특이도화준학성등.결과 대림파결전이적진단,CT적령민도위75.0%,특이도위59.6%,준학성66.7%.폐암조직중VEGF-C적표체양성솔위78.2% (68/87),기중강양성점13.8%(12/87),기대림파결전이적진단령민도위97.5%,특이도위38.3%,준학성위65.5%.당CT연합VEGF-C진단시,기령민도위80.0%,특이도위70.2%,준학성위74.7%.결론 CT검사연합VEGF-C표체검측능제고NSCLC폐문급종격림파결전이진단적특이성화준학성,우우CT혹VEGF-C단독응용,제시응용CT소묘진행림상N분기시,여능동시대암조직진행VEGF-C검측,가능회제고분기적준학성.
Objective To explore the diagnostic value of preoperative enhanced computed tomography (CT) plus vascular endothelial growth factor C (VEGF-C) expression in hilar and mediastinal lymph nodes metastasis of non-small cell lung cancer.Methods A total of 87 patients with non-small cell lung cancer (NSCLC) received preoperative chest enhanced CT scans and underwent standard radical operation and systematic lymph node dissection.Pathologic examination was selected as the gold standard to determine lymph node metastasis.The immunohistochemical method was used to detect the expression of VEGF-C.The predicting values of chest enhanced CT,VEGF-C expression and their combination for the diagnosis of hilar and medastinal lymph nodes metastasis were evaluated through comparing the sensitivity,specificity and accuracy.Results The sensitivity of CT scan was 75.0%,specificity 59.6% and accuracy 66.7%.The positive expression rate of VEGF-C was 78.2% (68/87) and strong positive rate 13.8% (12/87).The sensitivity of VEGF-C was 97.5%,specificity 38.3% and accuracy 65.5%.The combination of CT and VEGF-C had a better accuracy (74.7%) and the sensitivity and specificity were 80.0% and 70.2% respectively.Conclusion Compared with CT scan or VEGF-C expression alone,the combination of CT and VEGF-C improves the specificity and accuracy of diagnosing lymph nodes metastasis in NSCLC.If this combination method is employed before therapy,the accuracy of clinical nodal staging may be enhanced.